The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

Explore how evolving tools and emerging pathogens are reshaping the diagnosis and treatment of Pelvic Inflammatory Disease.

The Department of Health (DoH) has approved the roll-out of the world’s first vaccination programme to target gonorrhoea in ...

The rise in antibiotic-resistant "super-gonorrhoea" is "particularly concerning", according to the UK Health and Security ...

Adolescents who live in Kisumu’s informal settlements and are sexually active are likely to have chlamydia or gonorrhea, or ...

A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae bacteria. On average, the vaccine is effective in preventing gonorrhoea ...

Debio 1453 is a potent inhibitor of the essential fatty acid synthesis enzyme FabI found in N. gonorrhoeae and a few other bacterial species. It was shown to rapidly trigger bactericidal activity in ...

A world-first vaccine programme for gonorrhoea will be rolled out in England, officials have announced. The move aims to tackle rising levels of the sexually transmitted infection (STI) after ...

Gonorrhea is a sexually transmitted disease caused by Neisseria gonorrhoeae bacteria A new oral antibiotic, gepotidacin, may treat gonorrhea The drug showed similar success rates to current ...

For men, the infection can cause burning when you pee and sore testicles. Neisseria gonorrhoeae, the bacteria that causes gonorrhoea, was listed on the UKHSA’s "priority pathogen" watch list ...